Introduction
Diabetes Mellitus is a crippling disease affecting 387 million people worldwide. Diabetes is caused by the pancreas either not producing enough insulin or the cells not responding properly to the insulin produced. Since the body requires insulin for cells to uptake and thus reduce blood sugar, the common physiological symptom of diabetes is high blood sugar. The treatment of diabetes, therefore involves providing insulin doses. In a healthy non-diabetic condition, the body produces the requisite amount of insulin right after a meal to lower the blood glucose. With the aim of restoring carbohydrate metabolism to a normal state, the most common treatment of diabetes involves providing insulin supplements, also known as insulin therapy. In this section, we will go over four different means of taking insulin, with the last two means being intravenous. Then we will introduce a recent technology that allows for continuous glucose monitoring. We will conclude by illustrating how the Glucosystem IV takes the best features of all four means of insulin infusion and couples it with continuous glucose monitoring technology.
Insulin Syringes/Needles
Insulin Pumps
IV Based: Yale Insulin Infusion Protocol
IV Based Insulin: Glucommander Algorithm
Continuous Glucose Monitoring (CGM) Technology: Glucoset™
How Our Product is Different
Insulin Syringes/Needles
Insulin Pumps
IV Based: Yale Insulin Infusion Protocol
IV Based Insulin: Glucommander Algorithm
Continuous Glucose Monitoring (CGM) Technology: Glucoset™
How Our Product is Different